Latest oppositions filed by James Poole Limited

This table presents recent patent oppositions filed by James Poole Limited against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3283059Method For Producing Rna CompositionsCUREVAC AGOct 3, 2024
EP3227447Guide Rna With Chemical ModificationsAGILENT TECHNOLOGIES, INC.Sep 23, 2024
EP3763394Method For Labeling A Prostate-Specific Membrane Antigen Ligand With A Radioactive IsotopeISOTOPIA MOLECULAR IMAGING LTDAug 1, 2024
EP4108769A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow FiltrationCUREVAC MANUFACTURING GMBHMay 30, 2024
EP3531133Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia PatientsAMGENMay 21, 2024
EP3510402Detection Of Cancer Biomarkers Using NanoparticlesKOSTARELOS, KOSTASMay 14, 2024
EP4119677Spatially Distinguished, Multiplex Nucleic Acid Analysis Of Biological SpecimensILLUMINA, INC.Mar 28, 2024
EP2968536Methods For Modulating Chemotherapeutic CytotoxicityTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICESMar 27, 2024
EP3365356Nucleobase Editors And Uses ThereofPRESIDENT AND FELLOWS OF HARVARD COLLEGEMar 27, 2024
EP3566649Devices For Blood SamplingSEVENTH SENSE BIOSYSTEMS, INC.Mar 7, 2024